News Image

Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference

Provided By GlobeNewswire

Last update: Oct 13, 2025

Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer Pain

Session Co-Moderator Doug Beall, M.D. underscored that disc chemistry is the critical biomarker for diagnosing the leading cause of chronic low back pain

Read more at globenewswire.com

ACLARION INC

NASDAQ:ACON (11/13/2025, 8:13:43 PM)

6.15

-0.74 (-10.8%)


ACLARION INC -CW27

NASDAQ:ACONW (11/13/2025, 4:00:00 PM)

0.0432

0 (-6.09%)



Find more stocks in the Stock Screener

Follow ChartMill for more